As of June 10, 2025, AVAX Technologies Inc (AVXT) reports a Graham Number of 14.85.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of AVAX Technologies Inc's Graham Number
Over recent years, AVAX Technologies Inc's Graham Number has shown significant volatility. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2007-12-31 | 14.85 |
| 2006-12-31 | 0.04 |
| 2005-12-31 | 0.15 |
| 2004-12-31 | 17.60 |
This slight downward trend highlights how AVAX Technologies Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing AVAX Technologies Inc's Graham Number to Peers
To better understand AVAX Technologies Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| AVAX Technologies Inc (AVXT) | 14.85 |
| Adhera Therapeutics Inc (ATRX) | 3.42 |
| Biostage Inc (BSTG) | 2.17 |
| Protalix Biotherapeutics Inc (PLX) | 0.67 |
| Immune Pharmaceuticals Inc (IMNPQ) | 0.45 |
| Sangui Biotech International Inc (SGBI) | 0.00 |
Compared to its competitors, AVAX Technologies Inc's Graham Number is higher than all peers, suggesting potentially stronger fundamental value according to Graham's principles.